Soft-tissue lumps and bumps

Journal of Bone and Joint Surgery

Volumn 85, Issue 6, 2003, Pages 1142-1155

  Damron, Timothy A ^a   Beauchamp, Chris P ^b   Rougraff, Bruce T ^c   Ward, William G ^d  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b MAYO CLINIC   (United States)

^c Ortholndy   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; BIOPSY TECHNIQUE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EPITHELIOID SARCOMA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INCIDENCE; LABORATORY TEST; LYMPHOMA; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SKELETON RADIOGRAPHY; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA; SOFT TISSUE TUMOR; SURGEON; SURGICAL TECHNIQUE; SYMPTOM; TUMOR VOLUME; UNITED STATES;

EID: 0037675010     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200306000-00028     Document Type: Conference Paper

References (45)

1. Rydholm A, Berg NO, Gullberg B, Thorngren KG, Persson BM. Epidemiology of soft-tissue sarcoma in the locomotor system. A retrospective population-based study of the interrelationships between clinical and morphologic variables. Acta Pathol Microbiol Immunol Scand [A]. 1984;92:363-74.
2. Enneking WF. Musculoskeletal tumor surgery. Volume 1. New York: Churchill Livingstone: 1983. p 14-9.
3. Massengill AD, Seeger LL, Eckardt JJ. The role of plain radiography, computed tomography, and magnetic resonance imaging in sarcoma evaluation. Hematol Oncol Clin North Am. 1995; 9:571-604.
4. Sundaram M, McLeod RA. MR imaging of tumor and tumorlike lesions of bone and soft tissue. AJR Am J Roentgenol. 1990;155:817-24.
5. Richardson ML, Kilcoyne RF, Gillespy T 3rd, Helms CA, Genant HK. Magnetic resonance imaging of musculoskeletal neoplasms. Radiol Clin North Am. 1986;24:259-67.
6. Ben Arush MW, Israel O, Kedar Z, Goralnik L, Best LA, Meushar N, Elhasid R, Postovsky S. Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: case report. Pediatr Hematol Oncol. 2001;18:295-8.
7. Dimitrakopoulou-Strauss A, Strauss LG, Schwarzbach M, Burger C, Heichel T, Willeke F, Mechtershelmer G, Lehnert T. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading. J Nucl Med. 2001;42:713-20.
8. el-Zeftawy H, Helba SI, Jana S, Rosen G, Salem S, Santiago JF, Abdel-Dayem HM. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma. Cancer Biother Radiopharm. 2001;16:37-46.
9. Schwarzbach MH, Dimitrakopoulou-Strauss A, Mechtersheimer G, Hinz U, Willeke F, Cardona S, Attigah N, Strauss LG, Herfarth C, Lehnert T. Assessment of soft tissue lesions suspicious for liposarcoma by F 18-deoxyglucose (FDG) positron emission tomography (PET). Anticancer Res. 2001;21:3609-14.
10. Simon MA, Springfield D, editors. Surgery for bone and soft-tissue tumors. Philadelphia: Lippincott-Raven; 1998.
11. Springfield DS, Rosenberg A. Biopsy: complicated and risky. J Bone Joint Surg Am. 1996; 78:639-43.
12. Mankin HJ, Lange TA, Spanler SS. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am. 1982;64:1121-7.
13. Mankin HJ, Mankin CJ, Simon MA. The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society. J Bone Joint Surg Am. 1996;78:656-63.
14. Simon MA, Biermann JS. Biopsy of bone and soft-tissue lesions. J Bone Joint Surg Am. 1993;75:616-21.
15. Barth RJ Jr, Merino MJ, Solomon D, Yang JC, Baker AR. A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses. Surgery. 1992;112:536-43.
16. Kilpatrick SE, Ward WG, Chauvenet AR, Pettenati MJ. The role of fine-needle aspiration biopsy in the initial diagnosis of pediatric bone and soft tissue tumors: an institutional experience. Mod Pathol. 1998;11:923-8.
17. Moore TM, Meyers MH, Patzakis MJ, Terry R, Harvey JP Jr. Closed biopsy of musculoskeletal lesions. J Bone Joint Surg Am. 1979;61:375-80.
18. Schajowicz F, Derqui JC. Puncture biopsy in lesions of the locomotor system. Review of results in 4050 cases, including 941 vertebral punctures. Cancer. 1968;21:531-48.
19. Skrzynski MC, Biermann JS, Montag A, Simon MA. Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors. J Bone Joint Surg Am. 1996;78:644-9.
20. Shiu MH, Castro EB, Hajdu SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975;182:597-602.
21. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106-20.
22. Gibbs CP, Peabody TD, Mundt AJ, Montag AG, Simon MA. Oncological outcomes of operative treatment of subcutaneous soft-tissue sarcomas of the extremities. J Bone Joint Surg Am. 1997;79:888-97.
23. Giuliano AE, Eilber FR. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol. 1985;3:1344-8.
24. American Joint Committee on Cancer. Soft tissues. In: Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW, editors. AJCC cancer staging manual. 5th ed. Philadelphia: Lippincott-Raven; 1997. p 149-56.
25. Alvegard TA, Sigurdsson H, Mouridsen H, Solheim O, Unsgaard B, Ringborg U, Dahl O, Nordentoft AM, Blomqvist C, Rydholm A. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol. 1989;7:1504-13.
26. Antman K, Amato D, Lerner H, Suit HD, Corson J, Wood WC, Proppe K, Caray R, Greenberger J, Wilson R. Adjuvant doxorubicin for sarcom: data from the Eastern Cooperative Oncology Group and Dana-Farber Cancer Institute/Massachusetts General Hospital studies. Cancer Treat Syrup. 1985;3:109-15.
27. Benjamin RS, Terjanlan TO, Fenoglio CJ, Barkley HT, Evans HL, Murphy WK, Martin RG. The importance of combination chemotherapy for adjuvant treatment of high-risk patients with soft-tissue sarcomas of the extremities. In: Salmon SE, editor. Adjuvant therapy of cancer V. Orlando. FL: Grune and Stratton; 1987. p 735-44.
28. Bramwell V, Rouesse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, Ruka W, Priario J, Wagener T, Burgers M. Adjuvant CYVADIC chemotherapy for soft tissue sarcoma - reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1994;12:1137-49.
29. Casper ES, Gaynor JJ, Harrison LB, Panicek DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer. 1994;73:1644-51.
30. Chang AE, Kinsella T, Glatstein E, Baker AR, Sindelar WF, Lotze MT, Danforth DN Jr, Sugarbaker PH, Lack EE, Steinberg SM. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol. 1988;6:1491-500.
31. Edmonson JH, Fleming TR, Ivins JC, Burgert EO Jr, Soule EH, O'Connell MJ, Sim FH, Ahmann DL. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas. J Clin Oncol. 1984;2: 1390-6.
32. Edmonson JH. Role of adjuvant chemotherapy in the management of patients with soft tissue sarcomas. Cancer Treat Rep. 1984;68:1063-6.
33. Eilber FR, Giuliano AE, Huth JF, Morton DL. A randomized prospective trial using postoperative adjuvant chemotherapy (Adriamycin) in high, grade extremity soft-tissue sarcoma. Am J Clin Oncot. 1988;11:39-45.
34. Elias AD, Antman KH. Adjuvant chemotherapy for soft tissue sarcoma: an approach in search of an effective regimen. Semin Oncol. 1989;16:305-11.
35. Mertens WC, Bramwell VH. Adjuvant chemotherapy in the treatment of soft-tissue sarcoma. Clin Orthop. 1993;289:81-93.
36. Pezzi CM, Pollock RE, Evans HL, Lorigan JG, Pezzi TA, Benjamin RS, Romsdahl MM. Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg. 1990;211:476-81.
37. Phillips KA, Toner GC. Chemotherapy for soft tissue sarcomas. Indications and advances. Acta Orthop Scand Suppl. 1997;273:133-8.
38. Pinedo HM, Bramwell VH, Mouridsen HT, Somers R, Vendrik CP, Santoro A, Buesa J, Wagener T, van Oosterom AT, van Unnik JA, et al. Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer. 1984;53:1825-32.
39. Rosenberg SA, Tepper J, Glatstein E, Costa J, Young R, Baker A, Brennan MF, Demoss EV, Seipp C, Sindelar WF, Sugarbaker P, Wesley R. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 1983;52:424-34.
40. Saeter G. Chemotherapy for adult soft tissue sarcoma. Does it work? Acta Orthop Scand Suppl. 1997;273:139-44.
41. Santoro A, Tursz T, Mouridsen H, Verwelj J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1995;13:1537-45.
42. Tierney JF, Mossed V, Stewart LA, Souhami RL, Parmar MK. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials. Br J Cancer. 1995;72:469-75.
43. Tierney JF, Stewart LA, Parmar MKB. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350:1647-54.
44. Yarbro JW. Future potential of adjuvant and neoadjuvant therapy. Semin Oncol. 1991;18:613-9.
45. Rougraff BT, Durbin MA, Lawrence J, Buckwalter K. Histologic correlation with magnetic resonance imaging for benign and malignant lipomatous masses. Sarcoma. 1997;1:175-9.